about
KASL clinical practice guidelines: management of hepatitis CA systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohortA novel multiplex real-time PCR assay for the concurrent detection of hepatitis A, B and C viruses in patients with acute hepatitis.Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study.Prevalence of hepatitis C virus infections and distribution of hepatitis C virus genotypes among Korean blood donors.Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysisTreatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea.Type and cause of liver disease in Korea: single-center experience, 2005-2010.Behavioral and healthcare-associated risk factors for chronic hepatitis C virus infection in Korea.Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.Current status of and strategies for hepatitis C control in South KoreaClinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study.Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?The emerging importance of chronic hepatitis C infection in Asian Americans.KASL clinical practice guidelines: management of hepatitis C.Role of vitamin D in chronic hepatitis C.Viral Hepatitis in South Korea
P2860
Q26752471-6182188C-9A68-4275-8F41-004EEC7259EEQ30403548-CEEEB189-4062-49E1-A5D2-06EC47ED5DFAQ34459368-313F96E9-BD14-4939-8D44-C252D0B27272Q34474056-70B86D12-D26F-44B2-A604-0FFEDB3B4F2AQ35778355-1FEB86F6-3614-485E-9C9F-FDE8F016107BQ35919852-4C0C360F-7E85-4052-B6F2-461C4BC37696Q35942016-10CE4312-3C82-4A06-A2B4-1D73BA7E6A92Q36220201-5417FA49-BAFD-4FEE-AFB8-48D7C4BE1AA3Q36306710-E4936B89-E72C-4F2C-8AEC-FAC137176CDCQ36381931-8C177F72-1B01-43C6-85DC-10F5E9F35C4FQ40706753-FEE98755-6882-43CC-A55B-3399A9A3E70CQ41808225-12ADFB0A-1889-4C23-A5D0-BF98021AB145Q42286989-D8F73276-9F4C-43AF-A59F-EFF9FC03F6A2Q42988776-5F297F94-A936-442C-894C-733AF36616BFQ42994500-455DD36C-B059-4D65-840C-98ABCE1512A1Q43199205-321F4BE8-CE0C-4F20-B22A-F2A03C55A44CQ44600956-ED032A0B-9D5E-4AA6-9444-6F898614526BQ51836024-48604D38-BEE5-48E9-906F-2BE3123C5AFEQ55690522-4B53068E-D5BE-4F1B-87B1-810BC2D7CD14Q57212111-F89E07D5-4697-48F8-B826-FB1F0CC6B4CC
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Current status of hepatitis C virus infection in Korea.
@ast
Current status of hepatitis C virus infection in Korea.
@en
type
label
Current status of hepatitis C virus infection in Korea.
@ast
Current status of hepatitis C virus infection in Korea.
@en
prefLabel
Current status of hepatitis C virus infection in Korea.
@ast
Current status of hepatitis C virus infection in Korea.
@en
P2860
P356
P1433
P1476
Current status of hepatitis C virus infection in Korea.
@en
P2093
Dong Jin Suh
Sook-Hyang Jeong
P2860
P356
10.1159/000087266
P577
2006-01-01T00:00:00Z